Sinovac Biotech Ltd (NASDAQ:SVA)

4.94
Delayed Data
As of 3:59pm ET
 -0.01 / -0.20%
Today’s Change
4.51
Today|||52-Week Range
7.80
-5.54%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues33.4M56.8M49.2M72.5M
 
 
 
 
 
Cost of Goods Sold13.9M17.7M16.2M14.5M
 
 
 
 
 
Depreciation And Amortization4.2M4.8M4.5M6.7M
 
 
 
 
 
 
Operating ExpensesGross Income15.3M34.3M28.5M51.3M
 
 
 
 
 
General Expenses29.3M31.9M48.0M42.4M
 
 
 
 
 
Other Operating Expenses-1.9M0.000.000.00
 
 
Research And Development8.6M9.7M17.2M8.4M
 
 
 
 
 
Total Operating Expenses45.5M54.5M68.7M63.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-12.1M2.4M-19.5M8.8M
 
 
 
 
 
Extraordinary Charge-1.2M-455.0K---57.0K
 
 
 
 
Interest Expense On Debt1.3M980.4K2.2M3.1M
 
 
 
 
 
Other Expenses390.8K1.7M1.1M362.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-13.3M4.7M-19.6M8.1M
 
 
 
 
 
Income Taxes-703.9K-5.1M-883.9K-2.2M
 
 
 
 
 
Minority Interest-4.1M-445.0K-3.9M-2.9M
 
 
 
 
 
Net Income-8.5M-844.7K-14.9M7.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS53.1M54.6M54.9M55.3M
 
 
 
 
 
Shares To Calculate EPS Diluted53.1M54.6M54.9M55.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.16-$0.02-$0.27$0.13
 
 
 
 
 
EPS Diluted-$0.16-$0.02-$0.27$0.13
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account